Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.12 - $1.57 $8,665 - $12,147
-7,737 Reduced 16.78%
38,377 $57,000
Q3 2023

Nov 14, 2023

SELL
$1.07 - $1.39 $2,171 - $2,820
-2,029 Reduced 4.21%
46,114 $50,000
Q3 2023

Nov 14, 2023

BUY
$1.07 - $1.39 $2,171 - $2,820
2,029 Added 4.4%
48,143 $1.39 Million
Q1 2020

May 01, 2020

BUY
$1.27 - $3.0 $10,177 - $24,042
8,014 Added 21.03%
46,114 $72,000
Q3 2017

Oct 30, 2017

BUY
$2.18 - $2.57 $83,058 - $97,917
38,100
38,100 $97,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.84B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.